Skip to main content

Table 1 Association of SALL4 expression with clinicopathological parameters of ccRCC patients (TCGA Renal 2)

From: VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling

Parameters

Frequency (%)

SALL4 expression

P value

 

< median

≥median

Age (n = 481)

 < 60

222 (46.2)

112

110

0.822

 ≥ 60

259 (53.8)

128

131

 

Sex (n = 481)

 Male

313 (65.1)

148

165

0.118

 Female

168 (34.9)

92

76

 

T stage (n = 481)

 T1

237 (49.3)

133

104

0.003

 T2

62 (12.9)

35

27

 

 T3-T4

182 (37.8)

73

109

 

N stage (n = 224)

 N0

207 (92.4)

109

98

0.065

 N1+

17 (7.6)

5

12

 

M stage(n = 461)

 M0

390 (84.6)

203

187

0.051

 M1+

71 (15.4)

28

43

 

Tumor Grade (n = 455)

 Grade 1–2

213 (2.0)

122

91

0.003

 Grade 3

176 (38.7)

86

90

 

 Grade 4

66 (14.5)

22

44

 

AJCC stage (n = 436)

 Stage I

208 (47.7)

116

92

0.047

 Stage II

48 (11.0)

24

24

 

 Stage III

110 (25.2)

51

59

 

 Stage IV

70 (16.1)

26

44